Attention-deficit hyperactivity disorder (ADHD) is a common disorder of the school-age population. ADHD is familial, and genetic studies estimate heritability at 80%-90%. The aim of the present study was to investigate the association between the genetic type and alleles for the dopamine beta-hydroxylase (DBH) gene in Korean children with ADHD. The sample consisted of 142 ADHD children and 139 control children. We diagnosed ADHD according to DSM-IV. ADHD symptoms were evaluated with the Conners' Parent Rating Scales and Dupaul Parent ADHD Rating Scales. Blood samples were taken from the 281 subjects; DNA was extracted from blood lymphocytes, and polymerase chain reaction was performed for the DBH polymorphism. The alleles and genotype frequencies were compared using the chi-square test. We compared the allele and genotype frequencies of the DBH gene polymorphism in the ADHD and control groups. This study showed that there was a significant correlation among the frequencies of rs1611115 (odds ratio = 0.64, 95% confidence interval = 0.42-0.97, p = 0.034) of the alleles of DBH, but the final conclusions are not definite. Follow-up studies with larger patient or pure subgroups are expected. These results suggested that DBH might be related to ADHD symptoms.
Introduction
A ttention-Deficit Hyperactivity Disorder (ADHD) is a common childhood neuropsychiatric disorder characterized by behavioral problems such as attention deficit, hyperactivity, and impulsivity (American Psychiatric Association Committee on Nomenclature and Statistics, 1994) . It has a prevalence of 2%-7.6% among children of school age in Korea (Cho and Shin, 1994; Kim et al., 1999) . Family studies reported that ADHD showed a heredity as high as 80%-90% (Faraone and Doyle, 2001) , and molecular genetic studies are actively carried out accordingly. Recent genetic studies on ADHD have usually been conducted on the dopamine receptors and related neurotransmitters.
Dopamine beta-hydroxylase (DBH) is an enzyme that affects the metabolism of dopamine to noradrenaline, and plays an important role in catecholamine biosynthesis and the control of noradrenergic and adrenergic neurotransmission (O'Connor et al., 1994) . DBH is mainly distributed in the sympathetic terminals, adrenal glands, and the prefrontal cortex, and especially a high concentration of DBH was identified in the human prefrontal cortex (Gaspar et al., 1989) . The human DHBH-encoding gene is located at chromosome 9q34dp, and it is composed of 12 exons and consists of about a 23-kb sequence (Craig et al., 1988; Kobayashi et al., 1989) .
In the animal study using DBH knockout mice, it was reported that the DBH gene is related to behavior and cognition, and that deactivation of the DBH gene alters social memory and reduces aggression (Marino et al., 2005) . Thomas and Palmiter (1997) reported that lack of motor function as well as learning and memory was observed in the study of DBH knockout mice. In addition, there were studies on the relation between the DBH gene and human psychopathology. It was reported that decreased plasma DBH activity is related to bipolar disorder (Puzynski et al., 1983; Sofuoglu et al., 1995) and unipolar psychotic depression (Meyers et al., 1999; Cubells et al., 2002) . However, some studies reported that there is no relation between the plasma DBH activity and unipolar or bipolar disorder. On the other hand, it was reported that a low plasma DBH activity is related with conduct disorder and behavior problem for boys (Rogeness et al., 1982; Gabel et al., 1995) , and also reported that the plasma DBH activity is related with impulsive-hostile behaviors (Hess et al., 2009) .
DBH-rs1611115 is located 1,021 bp upstream of the transcription site of 50-flanking region in the DBH gene, and the Taq1A, rs2519152, which is a nonsynonymous singlenucleotide polymorphism (SNP), is located at intron 5 (Thomas and Palmiter, 1997) . DBH-rs1611115 explains 35%-52% of total variation for plasma DBH activity (Sofuoglu et al., 1995; Meyers et al., 1999; Cubells et al., 2002) . This correlation shows a higher value than the correlation for the 11 diallelic markers located near the DBH locus (Rogeness et al., 1982) . It was reported that homozygosity of the T allele is generally associated with low plasma activity, and homozygosity of the C allele is associated with high plasma activity and has a gene-dose effect (Gabel et al., 1995) . Recently, Chen et al. (2010) reported that the rs1611115( -970C > T) gene changes the DBH transcription at the cellular level. A Chinese clinical study (Zhang et al., 2005) first reported the association between DPH-1611115 and ADHD through a family study conducted with 292 nuclear families. They found that the T allele was preferentially transmitted in ADHD with disruptive behavior disorder.
The specific function of DBH-rs2519152(Taq 1A) is still not known, but it was reported to be related with the plasma DBH activity (D'mato et al., 1989; Wu et al., 1997) . Comings et al. (1996) first reported the relation between ADHD and the T allele (B1) of Taq 1A. However, this study was conducted on a very small number of subjects, and also had the disadvantage that it was a survey for ADHD accompanied by Tourette syndrome. Since then, a number of studies reported the relation between the Taq 1A and ADHD (Comings et al., 1996; Daly et al., 1999; Kirley et al., 2002; Wigg et al., 2002; Roman et al., 2002; Hawi et al., 2003; Smith et al., 2003; Inkster et al., 2004; Bhaduri and Mukhopadhyay, 2006; Tang et al., 2006; Kopecková et al., 2008) . Most of these studies were family based, and the study of Smith et al. (2003) was a case-control study. In Korea, the study of Park et al. (2005) is the only study for the relation between the DBH gene and ADHD. In the study that examined 78 ADHD children and their family control group, Park et al. (2005) reported that there is a relation between ADHD and the selective transmission of allele A1 of Taq 1A. Also, there has been no other study reporting on the correlation between neurodevelopmental disorders such as ADHD and DBH.
The aim of the present study was to investigate the association between the genetic type and alleles for the DBH gene in Korean children with ADHD.
Materials and Methods

Subjects
A questionnaire was conducted with about 16,000 elementary school students in a city whose population is about 500,000 from September 2008 and August 2010. An interview was performed randomly with the children whose Korean version of the Dupaul Attention Deficit Hyperactivity Disorder Rating Sales (K-ARS) (Kim et al., 2002) score was 19 or higher, and 142 ADHD children who consented to the genetic study were selected. For the control group, 139 children in the same area were selected by matching the sex and age of the subjects in the patient group. For both of the patient and control groups, a clinical evaluation and the DSM-IV diagnosis (American Psychiatric Association Committee on Nomenclature and Statistics, 1994) were performed by a child psychiatrist. The number of ADHD children was 142, including 101 boys (71.1%) and 41 girls (28.9%), and the mean age was 8.67 -0.84. The number of the children in the control group was 139, including 93 boys (66.9%) and 46 girls (33.1%), and the mean age was 8.65 -0.81. There was no significant difference in the sex and age between the two groups (Table 1) . Subjects were excluded from the study if there was any evidence of conduct disorder, mood disorder, anxiety disorder, Tourette disorder, pervasive development disorder, mental retardation (IQ < 70), and neurological disorders, including epilepsy. None of the children who participated in the study has ever undergone drug treatment before the evaluation. Informed consent was obtained before study entry. The study was also approved by the Hospital Ethics Committee. None of the children was taking psychostimulants at the time of the study.
On the day of visiting the hospital, the child psychiatrist performed a clinical interview as well as Kovac's Children's Depression Inventory (CDI) (Kovacs, 1983) , State Anxiety Inventory (SAIC), Trait Anxiety Inventory (TAIC) (Cho and Choi, 1989) , and Dupaul Attention Deficit Hyperactivity Disorder Rating Sales (K-ARS) (Kim et al. 2002) , computerized ADS (ADHD Diagnostic System) (Shin et al., 2000) , as well as completing a questionnaire survey regarding the pregnancy, infancy, developmental history, and anamnesis of the children with their parents. Subjects were included from our sample if they had a score over two standard deviations from the norm on the tests for ADS (T-score > 70). ADHD had a lot of cormorbid disorders, as depressive disorder and anxiety disorder. Therefore, we excluded children with the high score of depressive symptoms and anxiety symptoms. Subjects with 
DNA extraction and genotyping
DNA was extracted from leukocytes using a commercial DNA extraction kit, the Wizard Genomic DNA purification kit (Promega, Madison, WI). The DBH SNP was genotyped by polymerase chain reaction (PCR) according to the protocol described by studies (Cubells et al., 2000; Zabetian et al., 2001; Tang et al., 2006) . DBH rs1108580, rs1611115, and rs2519152 were genotyped by Illumina, Inc. (San Diego, CA) through the use of their Integrated Bead Array System. We supplied Illumina with barcoded DNA microtiter plates containing the DNA quantified with Pico Green to be at 100 ng/mL, and Illumina delivered genotypes with quality scores calculated by proprietary Illumina algorithms. Genotyping methods for the Korean samples were previously reported (Park et al., 2005) .
Statistical analysis
We performed independent t-tests for age, chi-square tests for sex, and chi-square tests to compare the results of the control group and the ADHD group through the frequency of the genotypes and alleles. SPSS PC software (version 15.0) was used for the statistical analysis, and the significance level was set to the p-value being < 0.05. The calculation revealed that a sample size of 210 subjects is required to obtain a power that is 95% or higher in the chi-square test between the control group and the patient group. Our study was conducted with 281 subjects, and the power was 97.41%. This indicates that the association of the DBH gene polymorphism and ADHD can be sufficiently accounted for by the results in this study. However, we performed the power program analysis for the chi-square test with 281 subjects, and the result showed that the effect size was 0.46 (moderate level).
Results
Demographic characteristics of the subjects
The subjects were a total of 281 children. The children in both of the ADHD group and the control group had never taken any psychostimulant in advance. There was no difference in the age (F = 0.05, p = 0.827) and sex (F = 0.52, p = 0.262) between the control group and the ADHD children group (Table 2) .
Comparison of the frequency of the genotypes and alleles with the genetic polymorphism of DBH between the control group and the ADHD group
The DBH-rs1611115 genotypes of the 139 subjects in the control group and the 142 subjects in the ADHD group were C/C (55.8%: 68.6%), C/T (39.9%: 29.3%), and T/T (4.4%: 2.1%), and there was a significant difference in the frequency between the two groups (v 2 = 2.18, df = 2, p = 0.029) (Table 3) .
Odds ratio of the genotypes and alleles with the genetic polymorphism of DBH between the control group and the ADHD group
For the DBH-rs1611115 genotype, the odds ratio was significant at 0.58 (confidence interval: 0.35-0.95, p = 0.029), and for the allele, the odds ratio was not significant at 0.64 (confidence interval: 0.42-0.97, p = 0.034) ( Table 3) .
Discussion
This study is a case-controlled study in which the frequency of the genotypes and alleles of DBH were compared between the ADHD children and the control group in Korea. The correlation between the genotypes and alleles of three candidate DBH SNPs was investigated. This study showed that there was a significant correlation between the frequencies of the DBH-rs1611115, and this result is reported for the first time in Korea. The association of DBH-rs1611115 in this study was matched up the result of Zhang et al.'s (2004 Zhang et al.'s ( , 2005 Kopecková et al. (2008) . In the only previous study of Korean children, Park et al. (2005) reported the association between the rs2519152 genetic polymorphism of the DBH gene and ADHD. However, in this study, the correlation between ADHD and the DBH-rs2519152 genetic polymorphism was not found, but the correlation between ADHD and the DBH-rs1611115 genetic polymorphism was found in this study for the first time.
The lack of association of DBH-rs1108580 in this study was matched by the result of Hawi et al. (2003) , Brookes et al.'s (2006) , Bhaduri and Mukhopadhyay's (2006) , Kopecková et al.'s (2008) , and Guan et al.'s (2009) study. However, one study found the association of DBH-rs1108580 and ADHD with A allele designated as the high-risk allele (Hawi et al., 2003) .
Combining the results about the correlation between the DBH-rs1611115 risky alleles and ADHD, it can be understood that failure of DBH regulation may cause changes in dopamine and may be correlated with the vulnerability of various psychiatric diseases, including ADHD and movement disorder. These receptors can affect the dopamine-mediating action, which is related with the symptoms found in the children with ADHD.
This study also suggests that the failure to regulate the DBH expression causes changes in the dopamine expression and the structural development of the brain regions related with nerve activity, attention, and impulsivity. In this study, we assumed that the variation of the DBH gene affects these SNPs that are the cause of ADHD. The analysis in the study of Guan et al., (2009) of 23 SNP genes showed that they were related to dopamine neurotransmission, including DBH, and that there was not a significant correlation between the DBH gene and ADHD. Hence, the correlation between the DBH gene and ADHD should be carefully handled, and the result of our study should be verified in the future study with a large number of independent samples. The limitations of this study are as follows: first, the number of subject children was small. The subjects of this study were 142 ADHD children and 139 children in the control group. Second, the results of this study may not be generalized for the cases of other racial or ethnic groups, since the frequency of alleles can vary due to local or racial differences. The distribution of the allele frequency in the ADHD patient children and parent group in this study was also different from that of other countries. Third, only a few SNPs were investigated in this study among the many genes related with the various ADHD phenotypes. Although it is clear that not just one genetic factor causes the increased ADHD vulnerability, we did not consider the interaction with other risk factors.
Despite the methodological limitations described before, this study has several advantages. First, the patient group and the control group were matched, so that there was no difference in the frequency of sex and age. The prevalence of ADHD is higher among men and in adolescence; thus, the sex and age characteristics can have a great effect. Considering this, our study was evaluated by matching the age and sex of the patient group and the control group with each other. Second, this study used population-based samples. Previous studies in Korea were hardly considered to represent the general population, because the subjects were usually ADHD children who visited hospitals for their clinical symptoms. In this study, the subjects in the risk group were selected by the questionnaire survey from the whole population in a region, and the patient and control samples were obtained by a random contact. Thus, the subjects in this study may be more appropriate to the characteristics of general population than those of the study performed with the patients who visited hospitals. Third, this study might have compared relatively homogenous groups that had the characteristics of Koreans, different from the studies conducted in other countries with subjects from various ethnic groups and nations. Fourth, both the patient group and control group in this study underwent clinical evaluation and DSM-IV diagnosis by children psychiatrists, applying the inclusion and exclusion criteria strictly, and thus the patient group was composed of subjects with pure ADHD.
We expect that different allele distribution results may be produced from future studies on the quantitative correlation of the ADHD performance in the pure ADHD group from which coexisting diseases are excluded, the patient group composed of only boys or girls, the subtype groups such as hyperactivitydominant group and attention-deficiency-dominant group, and the drug-response group.
